Our HPLC electrophoresis machine is specifically designed for efficient and accurate screening of sickle cell disease. Utilizing the principles of high-performance liquid chromatography (HPLC) and electrophoresis, this advanced system enables the separation and quantification of hemoglobin variants in blood samples.
With high sensitivity and resolution, our HPLC electrophoresis machine detects and differentiates normal hemoglobin (HbA) from abnormal variants, such as sickle hemoglobin (HbS). This screening method is crucial for identifying individuals at risk of sickle cell disease or carriers of the trait. Early detection allows for timely medical interventions, genetic counseling, and appropriate patient management.